Risk of neutropenic complications based on a prospective nationwide registry of cancer patients initiating systematic chemotherapy.
Publication
, Conference
Wolff, DA; Crawford, J; Dale, DC; Poniewierski, MS; Lyman, GH
Published in: JOURNAL OF CLINICAL ONCOLOGY
2004
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
ISSN
0732-183X
Publication Date
2004
Volume
22
Issue
14
Start / End Page
549S / 549S
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wolff, D. A., Crawford, J., Dale, D. C., Poniewierski, M. S., & Lyman, G. H. (2004). Risk of neutropenic complications based on a prospective nationwide registry of cancer patients initiating systematic chemotherapy. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 22, pp. 549S-549S).
Wolff, D. A., J. Crawford, D. C. Dale, M. S. Poniewierski, and G. H. Lyman. “Risk of neutropenic complications based on a prospective nationwide registry of cancer patients initiating systematic chemotherapy.” In JOURNAL OF CLINICAL ONCOLOGY, 22:549S-549S, 2004.
Wolff DA, Crawford J, Dale DC, Poniewierski MS, Lyman GH. Risk of neutropenic complications based on a prospective nationwide registry of cancer patients initiating systematic chemotherapy. In: JOURNAL OF CLINICAL ONCOLOGY. 2004. p. 549S-549S.
Wolff, D. A., et al. “Risk of neutropenic complications based on a prospective nationwide registry of cancer patients initiating systematic chemotherapy.” JOURNAL OF CLINICAL ONCOLOGY, vol. 22, no. 14, 2004, pp. 549S-549S.
Wolff DA, Crawford J, Dale DC, Poniewierski MS, Lyman GH. Risk of neutropenic complications based on a prospective nationwide registry of cancer patients initiating systematic chemotherapy. JOURNAL OF CLINICAL ONCOLOGY. 2004. p. 549S-549S.
Published In
JOURNAL OF CLINICAL ONCOLOGY
ISSN
0732-183X
Publication Date
2004
Volume
22
Issue
14
Start / End Page
549S / 549S
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences